No relapse of neuromyelitis optica during drug-induced B-lymphopenia with hypogammaglobulinemia.
Department of Neurology and Geriatrics, Graduate school of Medicine, Gifu University, 1-1 Yanagido, Gifu City, Gifu Prefecture, Japan, 501-1194. yutanaka-gif@umin.net
Yuji
Y
Tanaka
Kiminori
K
Kimura
Izumi
I
Kawachi
Takashi
T
Inuzuka
D000328:Adult; D000361:Agammaglobulinemia / Q000139:chemically induced / Q000175:diagnosis / Q000276:immunology*; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects*; D051401:Aquaporin 4 / Q000276:immunology; D001323:Autoantibodies / Q000096:biosynthesis; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000473:pathology; D005260:Female; D006801:Humans; D008231:Lymphopenia / Q000139:chemically induced* / Q000175:diagnosis* / Q000473:pathology; D009471:Neuromyelitis Optica / Q000175:diagnosis / Q000276:immunology / Q000517:prevention & control*; D000069283:Rituximab; D055502:Secondary Prevention
C496030:AQP4 protein, human; D058846:Antibodies, Monoclonal, Murine-Derived; D051401:Aquaporin 4; D001323:Autoantibodies; D000069283:Rituximab